SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950103-18-001529
Filing Date
2018-02-05
Accepted
2018-02-05 13:03:32
Documents
2
Group Members
BAXALTA GMBHSHIRE PLC

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G/A dp85903_sc13ga-4.htm SC 13G/A 57821
2 EXHIBIT 1 dp85903_ex01.htm EX-99.1 6690
  Complete submission text file 0000950103-18-001529.txt   66194
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 18573547
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015 224-940-2000
Baxalta Inc (Filed by) CIK: 0001620546 (see all company filings)

IRS No.: 471869689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations